Imbed Biosciences, located at University Research Park, received clearance from the FDA to market its Microlyte Ag wound dressing for prescription and over-the-counter use. ...
Madison’s high tech job growth far outpaced the national average from 2013 to 2015, with a 6.04 increase, ranking it 11th in the nation....
Madison is one of the top cities in the U.S. when it comes to growth in the tech-heavy industries that are pushing the nation’s economy forward, a report says....
The Mayor's Summit, held at University Research Park, brought together policymakers and city officials with entrepreneurs to learn how to create a stronger entrepreneurial ecosystem in their city....
Biotech has been one of the hottest sectors in the venture capital asset class over the past few years. Strong IPO and M&A markets have put wind in the sails of the space since 2012, and robust investment activity has enabled a wave of well-funded...
The Wisconsin Alumni Research Foundation needs to explain to the public that it is not the patent troll it was made out to be in the media....
FluGen, a Madison biotechnology company that is developing flu vaccines, has begun a clinical trial of its RedeeFlu universal influenza vaccine....
Fourteen research and infrastructure projects with the potential to transform robotics, cancer treatment, data science and more have been selected by the University of Wisconsin–Madison Office of the Vice Chancellor for Research and Graduate Education for support from the UW2020: WARF Discovery Initiative....
The Morgridge Institute seeks social entrepreneurs to apply for one of four $25,000 awards, recognizing organizations that take a business model approach to making a positive difference in Wisconsin....
The WARF Discovery Challenge is a two-part research competition open to UW–Madison graduate students and postdoctoral researchers from all departments....
Opera in the Park offers a sense of community, connectivity and common musical appreciation. A feast of food flavors and favorite arias....
Invenra's cell-free protein expression technology allows for the screening of hundreds of thousands of full antibodies, and is much faster than conventional cell-based methods for finding therapeutic antibodies....